SCHEMBL2372025

SCHEMBL2372025

CCCCCCCCCCC(C(=O)O)[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.53
FFAR1 O14842 2/20 0.53
MAPT P10636 1/20 0.52
LCK P06239 1/20 0.52
PPARD Q03181 1/20 0.52
ZDHHC20 Q5W0Z9 1/20 0.52
ZDHHC2 Q9UIJ5 1/20 0.52
ACE2 Q9BYF1 1/20 0.48
CA2 P00918 1/20 0.46
GRIK1 P39086 1/20 0.44
GRIK2 Q13002 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
CA1 P00915 2/20 0.44
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6333282 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2371368 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL6294388 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2370650 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2371272 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2371871 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2380100 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2370725 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2371133 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD
SCHEMBL2371890 1.00 GPR84 (0.53) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
CN-113302266-B Traction fluid 路博润公司 2023-02-24 CN disclosed
US-11384306-B2 Traction fluids THE LUBRIZOL CORPORATION (US) 2022-07-12 US disclosed
US-20220127539-A1 Traction Fluids LUBRIZOL CORP (US) 2022-04-28 US disclosed
US-20130039956-A1 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS Dietz, Ulrich (DE) 2013-02-14 US disclosed
EP-2547322-A2 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS Dietz, Ulrich (DE) 2013-01-23 EP disclosed
WO-2011113507-A2 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS DIETZ ULRICH (DE) 2011-09-22 WO disclosed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US disclosed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US disclosed
US-4468339-A AND SOLUBILIZER WHICH IS REACTION OF CARBOXYLIC ACID ACYLATING AGENT WITH HYDROCARBON SUBSTITMENT AND HYDROXYAMINE THE LUBRIZOL CORPORATION (US) 1984-08-28 US disclosed
US-4443577-A COLLOIDAL DISPERSE SYSTEM, OVERBASED SALTS THE LUBRIZOL CORPORATION (US) 1984-04-17 US disclosed
US-4436855-A DIISOCYANATE AND ORGANIC PHOSPHATE THE LUBRIZOL CORPORATION (US) 1984-03-13 US disclosed
EP-0094261-A2 One-component moisture curable urethane coating system The Lubrizol Corporation (US) 1983-11-16 EP disclosed
EP-0094196-A2 Two-component urethane coating system The Lubrizol Corporation (US) 1983-11-16 EP disclosed
EP-0084966-A2 Aqueous compositions containing overbased materials The Lubrizol Corporation (US) 1983-08-03 EP disclosed
US-4345045-A HEAT RESISTANCE DART INDUSTRIES, INC. (US) 1982-08-17 US disclosed
US-4278610-A SALT FORMATION, COMPLEXING NATIONAL RESEARCH LABORATORIES (US) 1981-07-14 US disclosed
EP-0008174-A1 Method of making an organic metal salt or complex NATIONAL RESEARCH LABORATORIES (US) 1980-02-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130039956-A1 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS NOS1, NOS2, NOS3 GPR84 1120/4885FFAR1 1269/4885MAPT 4513/4885
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 GPR84 3084/4885FFAR1 4474/4885MAPT 4074/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 GPR84 4406/4885FFAR1 3461/4885MAPT 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.